<DOC>
	<DOCNO>NCT00621803</DOCNO>
	<brief_summary>Preventing carriage potentially pathogenic micro-organism aerodigestive tract infection control strategy use reduce occurrence nosocomial infection - include ventilator-assisted pneumonia - intensive care unit . The use antibiotic controversial lead adverse effect selection highly resistant pathogen . The purpose study investigate effect oral administration probiotic strain , Lactobacillus , gastric respiratory tract colonisation/infection Pseudomonas aeruginosa strain , accord concept indigenous flora protective effect secondary colonisation .</brief_summary>
	<brief_title>Lcr35 / ICU / P. Aeruginosa</brief_title>
	<detailed_description>In prospective double-blind randomise study , ICU patient receive twice day either oral dose Lactobacillus casei rhamnosus , available pharmaceutical form , placebo . Digestive tract carriage Pseudomonas aeruginosa monitor culture gastric aspirate . The occurrence respiratory tract colonisation / infection monitor throughout study . Evaluation criterion delay rate gastric P. aeruginosa colonisation respiratory tract infection colonisation . Chi-square two tail Fisher exact test use compare qualitative variable Student 's t-test mann-Whitney test quantitatives variable . The mean non-acquisition expectancy ( NAE ) , length stay without P. aeruginosa acquisition , calculate P. aeruginosa non-colonized patient rate estimate two group compare regard survival curve group data use Kaplan Meier method Logrank test . Variables P. value â‰¤0.15 univariate analysis include logistic regression Cox regression model multivariate analysis .</detailed_description>
	<mesh_term>Pseudomonas Infections</mesh_term>
	<criteria>18 year old length stay longer 48h nasogastric feed tube le 18 year old length stay &lt; 48h immunosuppression absolute neutrophile count &lt; 500/mm3 gastrointestinal bleeding contraindicate enteral feed positive P. aeruginosa gastric aspirate respiratory tract specimen first four day hospital admission</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Probiotic</keyword>
	<keyword>Pseudomonas aeruginosa</keyword>
	<keyword>Gastric colonization</keyword>
	<keyword>Respiratory tract colonization</keyword>
	<keyword>Ventilator aquired pneumoniae</keyword>
	<keyword>determine effect oral administration probiotic gastric respiratory tract colonisation/infection P. aeruginosa</keyword>
</DOC>